Changeflow GovPing Healthcare Tandem Insulin Pump Recall - Czech Language Use...
Priority review Enforcement Removed Final

Tandem Insulin Pump Recall - Czech Language User Guide Translation Errors

Favicon for changeflow.com FDA: Device Recalls Class II
Filed April 1st, 2026
Detected April 7th, 2026
Email

Summary

FDA initiated a Class II recall (Z-1636-2026) of Tandem Diabetes Care insulin pumps due to translation errors in Czech language user guides distributed in Czech Republic and Slovakia. The critical error instructed users to verify the infusion set IS connected to the body when users should confirm it is NOT connected. The recall is ongoing as of April 1, 2026.

What changed

Tandem Diabetes Care initiated a Class II medical device recall affecting battery-operated insulin infusion pumps distributed internationally in Czech Republic and Slovakia. The Czech language user guide contained translation errors, the most significant being incorrect instructions for verifying infusion set connection status. Users were directed to confirm the set IS connected when the correct instruction should direct users to confirm it is NOT connected.

Medical device manufacturers and distributors with affected products should verify their inventory for Czech/Slovak language user guides and coordinate with Tandem Diabetes Care for corrected documentation. Healthcare providers treating patients using these devices should confirm patients have received accurate user guides. The recall remains ongoing with no specific return deadline provided.

What to do next

  1. Verify inventory for affected insulin pump user guides in Czech/Slovak languages
  2. Contact Tandem Diabetes Care to obtain corrected user guides
  3. Notify affected patients and healthcare providers of the translation error and provide updated materials

Source document (simplified)

Tandem Diabetes Care, Inc.

Device Recalls (Class II)

← All Device Recalls (Class II) Class II Z-1636-2026 · 20260401 · Ongoing

Product

Tandem pumps are battery-operated infusion pumps capable of both basal and bolus delivery of insulin. The pumps utilize a motor-driven mechanism to deliver insulin from within a disposable cartridg...

Reason for Recall

The Czech language user guide contained multiple translation errors. The most significant error was that it incorrectly instructs users to verify that the infusion set is connected to the body, when it should instead direct users to confirm that the infusion set is not connected to the body. Fol...

Distribution

International distribution in the countries of Czech Republic, Slovakia.

Source: openFDA Enforcement API

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
FDA
Filed
April 1st, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
Class II Z-1636-2026

Who this affects

Applies to
Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical Device Distribution User Guide Quality Control
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Compliance
Topics
Patient Safety Product Quality

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when FDA: Device Recalls Class II publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.